Attila Szanto Selected Research

Attila Szanto Research Topics

4	Inflammation (Inflammations) 12/2012 - 01/2008
3	Atherosclerosis 01/2008 - 09/2004
2	Neoplasms (Cancer) 01/2022 - 08/2011
2	Hypersensitivity (Allergy) 01/2021 - 08/2011
1	Malignant Mesothelioma 01/2022
1	Atherosclerotic Plaque (Atheroma) 03/2012
1	Granuloma 03/2012
1	Lipid Pneumonia 03/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2011
1	Autoimmune Diseases (Autoimmune Disease) 08/2011
1	Melanoma (Melanoma, Malignant) 08/2011
1	Disease Progression 01/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2011
1	Pathologic Processes 06/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2005

3	LipidsIBA 03/2012 - 11/2005
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2009 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 12/2012 - 11/2005
2	Liver X ReceptorsIBA 06/2009 - 01/2008
2	CholesterolIBA 06/2009 - 09/2004
1	tazemetostatIBA 01/2022
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2012
1	Interleukin-4 (Interleukin 4)IBA 12/2012
1	carboxypeptidase MIBA 03/2012
1	erucylphosphocholineIBA 03/2012
1	Differentiation AntigensIBA 03/2012
1	VaccinesIBA 08/2011
1	RNA Polymerase IIIIBA 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 08/2011
1	LigandsIBA 06/2009
1	OxysterolsIBA 06/2009
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2008
1	Lipoproteins (Lipoprotein)IBA 11/2005
1	factor XIII subunit AIBA 08/2005

1	Aftercare (After-Treatment) 01/2022
1	Therapeutics 01/2022